Trials / Completed
CompletedNCT03473262
Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes
Efficacy and Safety of Empagliflozin vs. Insulin Glargine add-on Therapy in Patients With Inadequately Controlled Type 2 Diabetes Under Triple Combination Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Chungbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy and safety of the empagliflozin as add-on thearpy compared to insulin glargine-based antidiabetic agents (OADs) combination thearpy in patients with type 2 diabetes inadequately controlled on triple OADs in a real clinical practice.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-07-18
- Completion
- 2018-07-18
- First posted
- 2018-03-22
- Last updated
- 2018-10-19
Source: ClinicalTrials.gov record NCT03473262. Inclusion in this directory is not an endorsement.